In a subcutaneous tumor model in mice, melatonin has also been observed to elicit marked inhibitory effects on tumor angiogenesis, lymphangiogenesis, and tumor growth through modulation of the NLRP3 axis. This evidence concerns the gene NLRP3 and neoplasm.